A retrospective study on unresectable or inoperable head and neck cancers treated with stereotactic ablative brachytherapy

SABT has produced good local control and mild adverse reactions in the treatment of unresectable or inoperable head and neck cancers. Additionally, it is safe, feasible, minimally invasive, and has fewer adverse effects than other treatment modalities.